ArticleFrontiers in oncology2026
Effect of methylene blue infusion into the inferior mesenteric artery on lymph node retrieval after transabdominal total mesorectal excision for rectal cancer: a retrospective cohort study.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to investigate the effect of methylene blue injection via the inferior mesenteric artery on lymph node retrieval in postoperative rectal cancer specimens. Materials and methods: This retrospective cohort study enrolled 120 patients undergoing radical rectal cancer resection by the same surgical team at a hospital in Bengbu City between July 2023 and December 2024. Among these, 60 patients operated on between April and December 2024 underwent heparinization of the surgical specimen post-extraction, followed by methylene blue arterial perfusion (experimental group). The remaining 60 patients, operated on between July 2023 and March 2024, received no special treatment after specimen removal (control group). The two groups were compared regarding total postoperative lymph node detection rates, positive lymph node detection rates, and average time per lymph node examined. Results: The experimental group exhibited a higher total number of lymph nodes detected and a higher total number of negative lymph nodes detected compared to the control group, with both differences being statistically significant [27.783 ± 9.243 vs. 15.317 ± 7.480, Conclusions: Methylene blue injection via the inferior mesenteric artery enhances the total number of lymph nodes detected post-rectal cancer surgery while reducing the average time per lymph node examination. This ensures accurate pathological staging and holds promise for providing more precise evidence for post-operative prognosis assessment and treatment planning in rectal cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.